Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access programEditta Baldini, Diana Giannarelli, Alice Lunghi et al.|Lung Cancer|2019Cited by 42
P2.03b-063 Molecular Profiling in Advanced Non-Small-Cell Lung Cancer: Preliminary Data of an Italian Observational Prospective StudyÉlisa Gobbini, Silvia Novello, Paola Bordi et al.|Journal of Thoracic Oncology|2017Cited by 0